Intravenous Equipment Market Is Expected To Reach US$ 16.1 Billion By 2027

The global intravenous equipment market is currently valued at US$ 12.3 billion and is predicted to reach US$ 16.1 billion by 2027, says Fact.MR, a market research and competitive intelligence provider.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7710?PS

Using intravenous equipment, nutrients or pharmaceuticals, such as insulin or hormones, chemotherapeutic medicines, antibiotics, and painkillers, can be administered directly into a vein. It is not necessary to use a new needle for each treatment once the IV cannula has been placed into the vein. The nurse or medical professional can then immediately administer medications, fluids, or blood into the bloodstream.

Based on product, the market is segmented into IV catheters, securement devices, administration sets, infusion sets, drip chambers, and others. IV catheters are highly demanded due to them being able to reduce complications during medical procedure. Peripheral IVs, central venous catheters, and midline catheters are the three primary subcategories of IV catheters. Several IVCs are utilised daily in hospitals depending on catheter type, and each catheter has a different use.

One of the main factors driving the demand for intravenous equipment globally is the rising importance of intravenous (IV) therapy. IV therapy is frequently administered to both surgical and non-surgical patients and is a crucial part of the treatment of many disorders. Another important reason propelling the expansion of the global intravenous equipment market is the rising prevalence of chronic diseases across the world. Cancer, heart disease, lung disease, kidney disease, and diabetes are examples of the most prevalent chronic diseases. Furthermore, the development of healthcare infrastructure in underdeveloped nations has opened up attractive potential opportunities for intravenous equipment suppliers.

High Use of Intravenous Equipment in Treatment of Several Serious Diseases"

It is predicted that the need for surgical treatments will increase steadily due to an ageing population with chronic conditions. One of the greatest options for such disorders is IV therapy equipment, which could be advantageous for suppliers of intravenous equipment.

Numerous drugs, including those for rheumatoid arthritis, osteoporosis, Crohn's disease, systemic lupus, psoriasis, multiple sclerosis, and gout, are administered via IV treatment.

Growing prevalence of chronic diseases, the increasing number of surgeries performed globally, the growing amount of intravenous (IV) drug approvals, and the growing technological advancements in intravenous devices are all contributing factors to the growth of the IV equipment market.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• Sales of IV catheters are predicted to rise at a CAGR of 6% from 2022 to 2027 and reach US$ 5 billion by 2027.
• The global intravenous equipment market is expected to expand at a CAGR of 5.6% from 2022 to 2027.
• The market in China is anticipated to surge ahead at a CAGR of 9% during the forecast period.
• Securement device sales are predicted to progress at a CAGR of 6.6% during the next five years.

𝐈𝐧𝐭𝐫𝐚𝐯𝐞𝐧𝐨𝐮𝐬 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

By Product :

IV Catheters
Securement Devices
Administration Sets
Infusion Sets
Drip Chambers
Others

End User :

Hospitals
Clinics
Ambulatory Care Centers
Others

By Region :

North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

𝐖𝐢𝐧𝐧𝐢𝐧𝐠 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲

Becton, Dickinson and Company, Terumo Medical Corporation, B. Braun Holding Gmbh & Co. Kg, Teleflex Medical Inc., and Medtronic Inc. are notable suppliers of intravenous systems.

The first and sole plug suitable/compatible with a microcatheter to occlude arteries up to 8 millimeters in diameter, the AZURTM Vascular Plug, was launched in July 2021, by Terumo Medical Corporation (TMC). In order to slow down or stop blood flow through the peripheral vasculature's arteries, this is used.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7710?PS

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

The market's major players are concentrating on integrating IV equipment such as IV infusion pumps with EHR technology.

Manufacturers of intravenous equipment are concentrating on leading economies to expand their market presence globally in light of the rapid growth in the healthcare sector.

A privately-owned company with its headquarters in Salamanca, Spain, Cytognos specializes in flow cytometry technologies for the diagnosis of blood cancer, detection of minimal residual disease, & immune monitoring study for blood disorders. In February 2022, BD (Becton, Dickinson and Company) announced its acquisition of Cytognos.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝

• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Fresenius SE & Co. KGaA
• Baxter International Inc.
• Smiths Medical
• ICU Medical, Inc.
• C. R. Bard, Inc.
• Terumo Corporation
• Moog, Inc.
• AngioDynamics, Inc.

𝐌𝐨𝐫𝐞 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐎𝐟𝐟𝐞𝐫

Fact.MR, in its new offering, presents an unbiased analysis of the global intravenous equipment market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.

The study divulges essential insights on the market on the basis of product (IV catheters, securement devices, administration sets, infusion sets, drip chambers, others) and end-user (hospitals, clinics, ambulatory care centers, others), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

Contact:

Us Sales Office :
11140 Rockville Pike
Suite 400
Rockville, Md 20852
United States
Tel: +1 (628) 251-1583

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.